Concerns about steep drug price increases are now focusing on Mylan's allergy treatment EpiPen.
Sen. Amy Klobuchar (D-Minn.) said in an Aug. 20 statement that a pack of two EpiPens cost $100 in 2009. Mylan is now selling the packs for $500, with some patients reportedly seeing prices as high as $600, she said. Klobuchar asked the Judiciary Committee to investigate.
Meanwhile, Sen. Charles Grassley (R-Iowa), chairman of the committee, sent a request Aug. 22 to Mylan for information on the pricing of EpiPen.
Grassley's letter said the cost of an EpiPen prescription “has implications for the federal taxpayers.” He said more than 40 percent of U.S. children are insured through Medicaid or the Children’s Health Insurance Program, adding that “many of the children who are prescribed EpiPens are covered by Medicaid and therefore the taxpayers are picking up the tab for this medication.”
The requests come as the drug industry has been criticized for its high prices, with some specific instances gaining notoriety. For example, in 2015, Turing Pharmaceuticals and its then-chief executive, Martin Shkreli, purchased a drug called Daraprim and immediately raised its price more than 5,000 percent. Daraprim is used to treat toxoplasmosis, a parasitic infection that can be life-threatening for people with HIV/AIDS, cancer and other conditions that cause compromised immune systems.
My full article is at http://www.bna.com/senators-question-price-n73014446716/.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)